Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

EMERGING MARKETS-Indian stocks hit record, Philippines falters after contrasting growth views

Published 12/04/2020, 03:24 PM
Updated 12/04/2020, 03:30 PM
© Reuters.

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh
* Graphic: Foreign flows into Asian stocks https://tmsnrt.rs/3lKhL5I
* Taiwan dollar, S.Korean won jump 1%
* Thai shares at highest since June 8

By Shashwat Awasthi
Dec 4 (Reuters) - Indian shares hit a record high on Friday
after the country's central bank upgraded its economic growth
forecast and said it would retain an accommodative policy stance
at least for the current financial year.
In contrast, stocks in the Philippines snapped a three-day
winning streak, hit by a forecast of a deeper economic
contraction this year and news that U.S. drugmaker Pfizer Inc
PFE.N had halved its COVID-19 vaccine production target for
2020.
Trading across other emerging Asian stock markets remained
mixed as sentiment around vaccines was partly offset by hopes
that a U.S. stimulus plan would be pushed through Congress.
Indian stocks .NSEI , which initially rose 0.6%, inched up
further after the Reserve Bank of India (RBI) projected positive
growth in the second half of 2021, while leaving interest rates
unchanged. "Indian equity markets have reacted positively to both an
upgrade of growth projection and availability of surplus
liquidity conditions," said Sameer Narang, chief economist at
Bank of Baroda.
Narang added foreign portfolio investment inflows were also
helping gains, and Friday's growth view upgrade implied the
inflows may continue to drive Indian equity markets.
The rupee INR= firmed 0.2% after two days of losses.
Shares in Manila .PSI dropped 0.8% and the peso PHP=
eased after officials on Thursday forecast a 8.5%-9.5%
contraction in the economy, compared with a previous forecast of
a 5.5% decline. Raul Ruiz, head of research at RCBC Securities, said vaccine
news was heavily affecting sentiment, and that a 15% rally in
stocks since October was giving way to profit-taking.
"News that the distribution of Pfizer's vaccine would be
constrained by supply chain issues probably has more bearing on
the market," Ruiz added.
"Considering that uncertainties with regard to COVID-19 have
yet to completely go away, there is a reluctance to letting
profits run."
Taiwan's dollar TWD=TP and South Korea's won KRW=KFTC
outperformed regional peers that failed to make significant
headway despite the U.S. dollar's woes, while shares in both
countries soared more than 1%.
Thai stocks .SETI , which gained in the previous session on
the promise of additional stimulus, climbed another 1% to a near
six-month high.
Thailand's central bank said on Thursday it had adjusted
rules on financial instruments qualified as banking capital to
ease lending to businesses and households, while data on Friday
showed deflation eased last month. ** Indonesian 3-year benchmark yields are down 3.6 basis
points at 4.796%
** In the Philippines, top index losers are SM Prime
SMPH.PS down 3.59%, Universal Robina URC.PS down 3.51% and
JG Summit JGS.PS down 3.17%
** Top gainers on Thailand's SETI include Union Plastic
UP.BK up 12.21%, Raimon Land RML.BK up 10% and Triple I
Logistics III.BK up​ 9.65%

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Asia stock indexes and currencies
at 0634 GMT
COUNTRY FX RIC FX FX YTD INDE STOCK STOC
DAILY % X S KS
% DAILY YTD
% %
Japan JPY= -0.03 +4.57 <.N2 -0.22 13.0
25> 8
China

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.